Published 2 months ago • loading... • Updated 2 months ago

Capstan Medical raises $110M for heart valve with robotic system

Summary by medtechdive.com

The startup’s third round of financing includes support from Intuitive Surgical’s venture capital arm.

7 Articles

All

Left

Center

Right

medtechdive.com

Capstan Medical raises $110M for heart valve with robotic system

The startup’s third round of financing includes support from Intuitive Surgical’s venture capital arm.

2 months ago

Read Full Article

MassDevice

Capstan Medical raises $110M ahead of heart robot’s first-in-human procedure - The Robot Report

Capstan Medical develops a surgical robot for minimally invasive percutaneous replacement of mitral and tricuspid heart valves.

2 months ago

Read Full Article

FinSMEs

Capstan Medical Raises $110M in Series C Funding

Capstan Medical, a Santa Cruz, CA-based developer of robotic-enabled minimally invasive solutions to address heart valve disease, raised $110M in Series C funding. The round was led by Eclipse, with participation from existing investors Yu Galaxy and Intuitive Ventures, and new investment from Gideon Strategic Partners. The company intends to use the funds to further advance its robotics technology. […] The post Capstan Medical Raises $110M in S…

2 months ago

Read Full Article

fundingblogger.com

Capstan Medical Secures $110M Series C Funding

SANTA CRUZ, CA, Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the successful closing of an oversubscribed $110 million Series C. Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the successful closing of an oversubscribed $110 million Series C to further advance its mission of bringing its innovative s…

2 months ago

Read Full Article

MobiHealthNews

Capstan Medical garners $110M for robotic-enabled heart valve repair

California-based Capstan Medical, maker of robotic-enabled tools for heart valve disease, closed an oversubscribed $110 million Series C round led by Eclipse. Existing investors Intuitive Ventures, Yu Galaxy, and new investor Gideon Strategic Partners, participated in the round. WHAT IT DOES The company offers surgical robotics with catheter-based technology and implants to repair and replace heart valves. It will use the funds to advance its r…

2 months ago

Read Full Article

Cardiac Interventions Today

Capstan Medical Secures Financing for Robotic Platform to Treat Heart Valve Disease - Cardiac Interventions Today

December 11, 2024—Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the closing of an oversubscribed $110 million Series C financing round to advance the company’s structural heart technology. According to Capstan, its minimally invasive solution seeks to bring together heart valve implants and catheter technology, enabled through a robotic platform, to treat a broad set of pat…

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year